Literature DB >> 24501588

Optimal Policies for Reducing Unnecessary Follow-up Mammography Exams in Breast Cancer Diagnosis.

Oguzhan Alagoz1, Jagpreet Chhatwal2, Elizabeth S Burnside3.   

Abstract

Mammography is the most effective screening tool for early diagnosis of breast cancer. Based on the mammography findings, radiologists need to choose from one of the following three alternatives: 1) take immediate diagnostic actions including prompt biopsy to confirm breast cancer; 2) recommend a follow-up mammogram; 3) recommend routine annual mammography. There are no validated structured guidelines based on a decision-analytical framework to aid radiologists in making such patient management decisions. Surprisingly, only 15-45% of the breast biopsies and less than 1% of short-interval follow-up recommendations are found to be malignant, resulting in unnecessary tests and patient-anxiety. We develop a finite-horizon discrete-time Markov decision process (MDP) model that may help radiologists make patient-management decisions to maximize a patient's total expected quality-adjusted life years. We use clinical data to find the policies recommended by the MDP model and also compare them to decisions made by radiologists at a large mammography practice. We also derive the structural properties of the MDP model, including sufficiency conditions that ensure the existence of a double control-limit type policy.

Entities:  

Keywords:  Markov decision processes; breast cancer diagnosis; double control-limit policy; mammography interpretation; medical decision making; practice

Year:  2013        PMID: 24501588      PMCID: PMC3910299          DOI: 10.1287/deca.2013.0272

Source DB:  PubMed          Journal:  Decis Anal        ISSN: 1545-8490


  43 in total

1.  Breast Imaging Reporting and Data System: inter- and intraobserver variability in feature analysis and final assessment.

Authors:  W A Berg; C Campassi; P Langenberg; M J Sexton
Journal:  AJR Am J Roentgenol       Date:  2000-06       Impact factor: 3.959

2.  Short-interval follow-up mammography: are we doing the right thing?

Authors:  Karla Kerlikowske; Rebecca Smith-Bindman; Edward A Sickles
Journal:  J Natl Cancer Inst       Date:  2003-03-19       Impact factor: 13.506

3.  Optimized approach to decision fusion of heterogeneous data for breast cancer diagnosis.

Authors:  Jonathan L Jesneck; Loren W Nolte; Jay A Baker; Carey E Floyd; Joseph Y Lo
Journal:  Med Phys       Date:  2006-08       Impact factor: 4.071

4.  BI-RADS categorization as a predictor of malignancy.

Authors:  S G Orel; N Kay; C Reynolds; D C Sullivan
Journal:  Radiology       Date:  1999-06       Impact factor: 11.105

5.  Potential of computer-aided diagnosis to reduce variability in radiologists' interpretations of mammograms depicting microcalcifications.

Authors:  Y Jiang; R M Nishikawa; R A Schmidt; A Y Toledano; K Doi
Journal:  Radiology       Date:  2001-09       Impact factor: 11.105

6.  Periodic mammographic follow-up of probably benign lesions: results in 3,184 consecutive cases.

Authors:  E A Sickles
Journal:  Radiology       Date:  1991-05       Impact factor: 11.105

7.  Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression.

Authors:  Carey K Anders; David S Hsu; Gloria Broadwater; Chaitanya R Acharya; John A Foekens; Yi Zhang; Yixin Wang; P Kelly Marcom; Jeffrey R Marks; Phillip G Febbo; Joseph R Nevins; Anil Potti; Kimberly L Blackwell
Journal:  J Clin Oncol       Date:  2008-07-10       Impact factor: 44.544

8.  Long-term psychosocial consequences of false-positive screening mammography.

Authors:  John Brodersen; Volkert Dirk Siersma
Journal:  Ann Fam Med       Date:  2013 Mar-Apr       Impact factor: 5.166

9.  Decreasing women's anxieties after abnormal mammograms: a controlled trial.

Authors:  Mary B Barton; Debra S Morley; Sara Moore; Jennifer D Allen; Ken P Kleinman; Karen M Emmons; Suzanne W Fletcher
Journal:  J Natl Cancer Inst       Date:  2004-04-07       Impact factor: 13.506

10.  Revisiting the mammographic follow-up of BI-RADS category 3 lesions.

Authors:  Ximena Varas; José H Leborgne; Francisco Leborgne; Julieta Mezzera; Sylvia Jaumandreu; Felix Leborgne
Journal:  AJR Am J Roentgenol       Date:  2002-09       Impact factor: 3.959

View more
  7 in total

1.  A Value-of-Information Framework for Personalizing the Timing of Surveillance Testing.

Authors:  Aasthaa Bansal; Patrick J Heagerty; Lurdes Y T Inoue; David L Veenstra; Charles J Wolock; Anirban Basu
Journal:  Med Decis Making       Date:  2021-11-07       Impact factor: 2.583

2.  Dual-Intended Deep Learning Model for Breast Cancer Diagnosis in Ultrasound Imaging.

Authors:  Nicolle Vigil; Madeline Barry; Arya Amini; Moulay Akhloufi; Xavier P V Maldague; Lan Ma; Lei Ren; Bardia Yousefi
Journal:  Cancers (Basel)       Date:  2022-05-27       Impact factor: 6.575

Review 3.  Magnetic resonance elastography (MRE) in cancer: Technique, analysis, and applications.

Authors:  Kay M Pepin; Richard L Ehman; Kiaran P McGee
Journal:  Prog Nucl Magn Reson Spectrosc       Date:  2015-06-23       Impact factor: 9.795

4.  Changing Cycle Lengths in State-Transition Models: Challenges and Solutions.

Authors:  Jagpreet Chhatwal; Suren Jayasuriya; Elamin H Elbasha
Journal:  Med Decis Making       Date:  2016-07-01       Impact factor: 2.583

5.  Added Value of Contrast-Enhanced Ultrasound on Biopsies of Focal Hepatic Lesions Invisible on Fusion Imaging Guidance.

Authors:  Tae Wook Kang; Min Woo Lee; Kyoung Doo Song; Mimi Kim; Seung Soo Kim; Seong Hyun Kim; Sang Yun Ha
Journal:  Korean J Radiol       Date:  2017-01-05       Impact factor: 3.500

6.  Diagnostic Policies Optimization for Chronic Diseases Based on POMDP Model.

Authors:  Wenqian Zhang; Haiyan Wang
Journal:  Healthcare (Basel)       Date:  2022-02-01

7.  A new perspective on breast cancer diagnostic guidelines to reduce overdiagnosis.

Authors:  Sait Tunç; Oguzhan Alagoz; Elizabeth S Burnside
Journal:  Prod Oper Manag       Date:  2022-03-08       Impact factor: 4.638

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.